Related Experiment Video
Updated: Aug 10, 2026
14:57
Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology
Published on: March 23, 2011
Norepinephrine decreases synaptic inhibition in the rat hippocampus
1Department of Pharmacology, University of California, San Francisco 94143.
Brain Research
|February 23, 1988
Summary
Norepinephrine (NE) reduces inhibitory postsynaptic potentials (IPSPs) in hippocampal CA1 pyramidal neurons. This disinhibition enhances excitatory postsynaptic potentials (EPSPs), leading to increased neuronal firing and multiple population spikes.
Area of Science:
- Neuroscience
- Synaptic Plasticity
- Neuropharmacology
Background:
- Norepinephrine (NE) is a key neurotransmitter modulating brain function.
- Inhibitory and excitatory synaptic potentials shape neuronal activity in the hippocampus.
- CA1 pyramidal neurons are crucial for learning and memory.
Purpose of the Study:
- To investigate the effects of norepinephrine on inhibitory synaptic potentials in CA1 pyramidal neurons.
- To elucidate the mechanisms underlying norepinephrine-induced changes in neuronal excitability.
Main Methods:
- In vitro electrophysiological recordings from hippocampal slices.
- Intracellular recording of inhibitory postsynaptic potentials (IPSPs) and excitatory postsynaptic potentials (EPSPs).
- Application of norepinephrine and assessment of gamma-aminobutyric acid (GABA) responses.
Main Results:
- Norepinephrine significantly reduced evoked IPSPs in CA1 pyramidal cells.
- This reduction in inhibition led to larger EPSPs and increased neuronal firing, causing multiple population spikes.
- The effect was mediated by alpha-receptors and occurred presynaptically, without altering GABA reversal potentials.
Conclusions:
- Norepinephrine exerts a disinhibitory effect on CA1 pyramidal neurons by reducing IPSPs.
- This action enhances neuronal excitability and may contribute to altered network activity.
- The findings suggest a presynaptic modulatory role for norepinephrine in hippocampal circuits.
Related Concept Videos
01:29Excitatory and Inhibitory Effects of Neurotransmitters
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of specific...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...